SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction

被引:18
作者
Vuletic, S. [1 ]
Taylor, B. A. [2 ]
Tofler, G. H. [3 ]
Chait, A. [1 ]
Marcovina, S. M. [1 ]
Schenck, K. [4 ]
Albers, J. J. [1 ]
机构
[1] Univ Washington, NW Lipid Metab & Diabet Res Labs, Dept Med, Seattle, WA 98109 USA
[2] Sydney Dent Hosp, Sydney, NSW, Australia
[3] Royal N Shore Hosp, Sydney, NSW, Australia
[4] Univ Oslo, Dept Oral Biol, Oslo, Norway
关键词
periodontitis; SAA; PLTP;
D O I
10.1111/j.1601-0825.2007.01411.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
OBJECTIVE: To assess whether treatment of advanced periodontal disease affects plasma levels of serum amyloid A (SAA) and phospholipid transfer protein (PLTP) activity. DESIGN:We measured the levels of SAA and PLTP activity in plasma of 66 patients with advanced periodontal disease before and after treatment by full-mouth tooth extraction (FME). RESULTS: At baseline, median SAA levels in our study population were within the normal range (2.7 mu g ml(-1)) but SAA was elevated (> 5 mu g ml(-1)) in 18% of periodontitis patients. Three months after FME, SAA levels were significantly reduced (P = 0.04). SAA did not correlate with any of the periodontal disease parameters. PLTP activity was elevated in patients with periodontitis, compared to the PLTP activity reference group (age-matched systemically healthy adults, n = 29; 18 mu mol ml(-1) h(-1)vs 13 mu mol ml(-1) h(-1), respectively, P = 0.002). PLTP activity inversely correlated with average periodontal pocket depth (PPD) per tooth (r(s) = -0.372; P = 0.002). Three months after FME, median PLTP activity did not change significantly. CONCLUSIONS: Full-mouth tooth extraction significantly reduces SAA, a marker of inflammation, while it does not affect plasma PLTP activity. However, the inverse correlation between PLTP activity and average PPD suggests that increased PLTP activity may limit periodontal tissue damage.
引用
收藏
页码:514 / 519
页数:6
相关论文
共 41 条
[1]  
Barlage S, 2001, J LIPID RES, V42, P281
[2]   Meet the relatives: a family of BPI- and LBP-related proteins [J].
Bingle, CD ;
Craven, CJ .
TRENDS IN IMMUNOLOGY, 2004, 25 (02) :53-55
[3]  
Cabana VG, 1996, J LIPID RES, V37, P2662
[4]   Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? [J].
Chait, A ;
Han, CY ;
Oram, JF ;
Heinecke, JW .
JOURNAL OF LIPID RESEARCH, 2005, 46 (03) :389-403
[5]   Plasma phospholipid mass transfer rate: Relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters [J].
Cheung, MC ;
Wolfbauer, G ;
Albers, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1303 (02) :103-110
[6]  
CHEUNG MC, 2005, BIOCHIM BIOPHYS ACTA, V1762, P131
[7]  
CLIFTON PM, 1985, J LIPID RES, V26, P1389
[8]   Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering α-tocopherol to endothelial cells [J].
Desrumaux, C ;
Deckert, V ;
Athias, A ;
Masson, D ;
Lizard, G ;
Palleau, V ;
Gambert, P ;
Lagrost, L .
FASEB JOURNAL, 1999, 13 (08) :883-892
[9]   Systemic inflammation in cardiovascular and periodontal disease: Comparative study [J].
Glurich, I ;
Grossi, S ;
Albini, B ;
Ho, A ;
Shah, R ;
Zeid, M ;
Baumann, H ;
Genco, RJ ;
De Nardin, E .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (02) :425-432
[10]   A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage [J].
Gronert, K ;
Kantarci, A ;
Levy, BD ;
Clish, CB ;
Odparlik, S ;
Hasturk, H ;
Badwey, JA ;
Colgan, SP ;
Van Dyke, TE ;
Serhan, CN .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1856-1861